Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

Outcome after thrombolytic therapy of nine cases of myopericarditis misdiagnosed as myocardial infarction.

Millaire A, de Groote P, Decoulx E, Leroy O, Ducloux G.

Eur Heart J. 1995 Mar;16(3):333-8.

PMID:
7789375
2.

Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients.

Grijseels EW, Bouten MJ, Lenderink T, Deckers JW, Hoes AW, Hartman JA, van der Does E, Simoons ML.

Eur Heart J. 1995 Dec;16(12):1833-8.

PMID:
8682015
3.

Cardiac tamponade early after thrombolysis for acute myocardial infarction: a rare but not reported hemorrhagic complication.

Renkin J, de Bruyne B, Benit E, Joris JM, Carlier M, Col J.

J Am Coll Cardiol. 1991 Jan;17(1):280-5.

4.

Inadvertent administration of streptokinase to patients with pericarditis.

Tilley WS, Harston WE.

Am J Med. 1986 Sep;81(3):541-4.

PMID:
3752151
5.

[The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].

Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.

Ital Heart J Suppl. 2000 Jan;1(1):81-7. Italian.

PMID:
10832123
6.

[Varicella zoster myopericarditis in an immunocompetent adult].

Biocić S, Durasević Z, Starcević B, Udovicić M.

Acta Med Croatica. 2009 Oct;63(4):325-7. Croatian.

PMID:
20034334
7.
8.
9.

Pericarditis and pericardial effusion in acute ST-elevation myocardial infarction in the thrombolytic era.

Aydinalp A, Wishniak A, van den Akker-Berman L, Or T, Roguin N.

Isr Med Assoc J. 2002 Mar;4(3):181-3.

PMID:
11908258
10.

Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)

Langer A, Goodman SG, Topol EJ, Charlesworth A, Skene AM, Wilcox RG, Armstrong PW.

J Am Coll Cardiol. 1996 May;27(6):1327-32.

11.

[Usefulness of thrombolytic therapy with low doses of streptokinase in acute myocardial infarction].

Raffo C, Bartolucci J, Corbalán R, Aninat M, Torres H, Prieto JC, Lanas F, Chávez E, Cumsille F, Nazzal C; Grupo de Estudio Multicéntrico del Infarto.

Rev Med Chil. 2006 Oct;134(10):1249-57. Epub 2006 Dec 13. Spanish.

12.

Clinical pitfalls in the non-invasive thrombolytic approach to presumed acute myocardial infarction.

Ferguson DW, Dewey RC, Plante DA.

Can J Cardiol. 1986 May-Jun;2(3):146-51.

PMID:
3719448
13.

[Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].

Mukawa H, Sone T, Tsuboi H, Kondo J, Kosokabe T, Uesugi M, Imai H.

J Cardiol. 2001 Apr;37(4):181-9. Japanese.

PMID:
11337927
14.

Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction.

Belkin RN, Mark DB, Aronson L, Szwed H, Califf RM, Kisslo J.

Am J Cardiol. 1991 Mar 1;67(6):496-500.

PMID:
1900139
15.

Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) Project.

Kudenchuk PJ, Maynard C, Cobb LA, Wirkus M, Martin JS, Kennedy JW, Weaver WD.

J Am Coll Cardiol. 1998 Jul;32(1):17-27.

16.

"Inadvertent" thrombolytic administration in patients without myocardial infarction: clinical features and outcome.

Khoury NE, Borzak S, Gokli A, Havstad SL, Smith ST, Jones M.

Ann Emerg Med. 1996 Sep;28(3):289-93.

PMID:
8780471
17.

[Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998].

Sauvant G, Bossart W, Kurrer MO, Follath F.

Schweiz Med Wochenschr. 2000 Sep 9;130(36):1265-71. German.

PMID:
11028270
19.

Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.

Morgan CD, Gent M, Daly PA, Baigrie RS, Haq A, Roberts RS, Armstrong PW.

Can J Cardiol. 1994 Nov;10(9):897-904.

PMID:
7954025
20.

[Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction].

Acar J, Dorent R, Vahanian A, Michel PL, Cormier B, Slama M, Cazaux P, Conard J, Verdy E, Samama M.

Arch Mal Coeur Vaiss. 1988 May;81 Spec No:59-65. French.

PMID:
3142430

Supplemental Content

Support Center